289 related articles for article (PubMed ID: 19349657)
1. Comparison of PDR brachytherapy and external beam radiation therapy in the case of breast cancer.
Teymournia L; Berger D; Kauer-Dorner D; Poljanc K; Seitz W; Aiginger H; Kirisits C
Phys Med Biol; 2009 Apr; 54(8):2585-95. PubMed ID: 19349657
[TBL] [Abstract][Full Text] [Related]
2. Lung and cardiac tissue doses in left breast cancer patients treated with single-source breast brachytherapy compared to external beam tangent fields.
Garza R; Albuquerque K; Sethi A
Brachytherapy; 2006; 5(4):235-8. PubMed ID: 17118316
[TBL] [Abstract][Full Text] [Related]
3. Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy.
Pieters BR; van de Kamer JB; van Herten YR; van Wieringen N; D'Olieslager GM; van der Heide UA; Koning CC
Radiother Oncol; 2008 Jul; 88(1):46-52. PubMed ID: 18378028
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
5. Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy.
Lettmaier S; Kreppner S; Lotter M; Walser M; Ott OJ; Fietkau R; Strnad V
Radiother Oncol; 2011 Aug; 100(2):189-94. PubMed ID: 20673690
[TBL] [Abstract][Full Text] [Related]
6. Late chest wall toxicity after MammoSite breast brachytherapy.
Brashears JH; Dragun AE; Jenrette JM
Brachytherapy; 2009; 8(1):19-25. PubMed ID: 18955019
[TBL] [Abstract][Full Text] [Related]
7. MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer.
Lindegaard JC; Tanderup K; Nielsen SK; Haack S; Gelineck J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):756-64. PubMed ID: 18191335
[TBL] [Abstract][Full Text] [Related]
8. Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints.
Lang S; Kirisits C; Dimopoulos J; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):619-27. PubMed ID: 17869676
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric parameters in partial breast irradiation through brachytherapy.
Gloi A; McCourt S; Buchanan R; Goetller A; Zuge C; Balzoa P; Cooley G
Med Dosim; 2009; 34(3):207-13. PubMed ID: 19647630
[TBL] [Abstract][Full Text] [Related]
10. Critical organ preservation in reirradiation brachytherapy by injectable spacer.
Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885
[TBL] [Abstract][Full Text] [Related]
11. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
[TBL] [Abstract][Full Text] [Related]
13. Optimization and it's influence on value of doses in HDR and PDR brachytherapy.
Skowronek J; Zwierzchowski G; Piotrowski T; Milecki P
Neoplasma; 2010; 57(4):369-76. PubMed ID: 20429630
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer.
Major T; Niehoff P; Kovács G; Fodor J; Polgár C
Radiother Oncol; 2006 Jun; 79(3):321-8. PubMed ID: 16730085
[TBL] [Abstract][Full Text] [Related]
15. Biological effective dose for comparison and combination of external beam and low-dose rate interstitial brachytherapy prostate cancer treatment plans.
Jani AB; Hand CM; Lujan AE; Roeske JC; Zagaja GP; Vijayakumar S; Pelizzari CA
Med Dosim; 2004; 29(1):42-8. PubMed ID: 15023392
[TBL] [Abstract][Full Text] [Related]
16. Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.
Semenenko VA; Li XA
Phys Med Biol; 2008 Feb; 53(3):737-55. PubMed ID: 18199912
[TBL] [Abstract][Full Text] [Related]
17. A dosimetric analysis comparing electron beam with the MammoSite brachytherapy applicator for intact breast boost.
Shah AP; Strauss JB; Kirk MC; Chen SS; Dickler A
Phys Med; 2010 Apr; 26(2):80-7. PubMed ID: 19836283
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of two different three-dimensional conformal external beam accelerated partial breast irradiation techniques.
Kozak KR; Doppke KP; Katz A; Taghian AG
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):340-6. PubMed ID: 16690427
[TBL] [Abstract][Full Text] [Related]
19. Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy.
Korreman SS; Pedersen AN; Josipović M; Aarup LR; Juhler-Nøttrup T; Specht L; Nyström H
Radiother Oncol; 2006 Aug; 80(2):257-62. PubMed ID: 16905210
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models.
Bovi J; Qi XS; White J; Li XA
Radiother Oncol; 2007 Sep; 84(3):226-32. PubMed ID: 17692980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
